These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 35474453)
41. Mitochondrial DNA polymorphisms and biogenesis genes in primary and metastatic uveal melanoma cell lines. Singh L; Atilano SR; Jager MJ; Kenney MC Cancer Genet; 2021 Aug; 256-257():91-99. PubMed ID: 34082186 [TBL] [Abstract][Full Text] [Related]
42. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review. Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428 [TBL] [Abstract][Full Text] [Related]
43. Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture. Aughton K; Shahidipour H; Djirackor L; Coupland SE; Kalirai H Transl Vis Sci Technol; 2020 Jun; 9(7):39. PubMed ID: 32832244 [TBL] [Abstract][Full Text] [Related]
44. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma. Klisovic DD; Klisovic MI; Effron D; Liu S; Marcucci G; Katz SE Melanoma Res; 2005 Jun; 15(3):147-53. PubMed ID: 15917695 [TBL] [Abstract][Full Text] [Related]
45. Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology. Sun S; Shi R; Xu L; Sun F Melanoma Res; 2022 Feb; 32(1):18-26. PubMed ID: 34879031 [TBL] [Abstract][Full Text] [Related]
46. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition. Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166 [TBL] [Abstract][Full Text] [Related]
48. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential. Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486 [TBL] [Abstract][Full Text] [Related]
49. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma. Li J; Liu X; Li C; Wang W J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222 [TBL] [Abstract][Full Text] [Related]
50. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035 [TBL] [Abstract][Full Text] [Related]
51. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3. Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633 [TBL] [Abstract][Full Text] [Related]
52. Prognostic Factors Five Years After Enucleation for Uveal Melanoma. Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma. Calipel A; Landreville S; De La Fouchardière A; Mascarelli F; Rivoire M; Penel N; Mouriaux F Clin Exp Metastasis; 2014 Jun; 31(5):553-64. PubMed ID: 24652072 [TBL] [Abstract][Full Text] [Related]
54. Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients. Tura A; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S; Lüke J Pigment Cell Melanoma Res; 2016 Sep; 29(5):583-9. PubMed ID: 27390171 [TBL] [Abstract][Full Text] [Related]
55. Evolutionary Routes in Metastatic Uveal Melanomas Depend on Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496 [TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor. Wang Y; Liu M; Jin Y; Jiang S; Pan J Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241 [TBL] [Abstract][Full Text] [Related]
58. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma. Jiang Z; Liu F Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142 [TBL] [Abstract][Full Text] [Related]
59. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
60. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]